Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. Juni 2018 08:00 ET | Quelle: Precipio, Inc.

Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018

NEW HAVEN, Conn., June 12, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today reminded its shareholders to vote on proposals 1-6 in accordance with the...
06. Juni 2018 07:38 ET | Quelle: Precipio, Inc.

Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology

NEW HAVEN, Conn., June 06, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced the award of US patent No. 9,957,556 entitled FULL COLD-PCR...
24. Mai 2018 07:38 ET | Quelle: Precipio, Inc.

Precipio Launches Liquid Biopsy DNA Enrichment Sales in Europe with First Order

$10 million annual Europe market anticipated with $1 million annual addressable sales potential from local Italy partner NEW HAVEN, Conn., May 24, 2018 (GLOBE NEWSWIRE) -- Specialty cancer...
22. Mai 2018 07:37 ET | Quelle: Precipio, Inc.

Potential Sequential Revenue Run-Rate Growth of 30% over Q1, based on Preliminary April Results

NEW HAVEN, Conn., May 22, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced accelerating sales of its Pathology services in the month of...
17. Mai 2018 07:38 ET | Quelle: Precipio, Inc.

Precipio Launches ICE COLD-PCR™ Liquid Biopsy Kit for Pancreatic Cancer

Ultra-sensitive enrichment kit enables development of low cost detection tests, allowing optimized patient treatment NEW HAVEN, Conn., May 17, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company...
14. Mai 2018 07:37 ET | Quelle: Precipio, Inc.

Precipio Announces Preliminary Q1 2018 Year-over-Year Revenue Increase of 286%

Growth resulting from commercial team reorganization, product and service cross-selling, and increased business stabilization NEW HAVEN, Conn., May 14, 2018 (GLOBE NEWSWIRE) -- Specialty...
26. April 2018 07:38 ET | Quelle: Precipio, Inc.

Precipio Announces Participation Details for Upcoming Shareholder Conference Call

NEW HAVEN, Conn., April 26, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), provides details of its previously announced upcoming shareholder conference call...
23. April 2018 07:37 ET | Quelle: Precipio, Inc.

Precipio Completes a $3M Convertible Debt Facility

Management focuses on growth opportunities NEW HAVEN, Conn., April 23, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that it entered into a...
18. April 2018 07:38 ET | Quelle: Precipio, Inc.

Precipio in Strategic Partnership Discussions for Proprietary Cytogenetics Media IV-Cell

NEW HAVEN, Conn., April 18, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it is in active licensing discussions with several potential partners...
17. April 2018 07:37 ET | Quelle: Precipio, Inc.

Precipio Releases its 2017 10-K, Files a form S-1, and hosts Fourth Quarter and Full Year Update Call

Management to provide strategic business update to shareholders NEW HAVEN, Conn., April 17, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that...

Vorherige Seite

Nächste Seite